BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nephew LD, Serper M. Racial, Gender, and Socioeconomic Disparities in Liver Transplantation. Liver Transpl 2021;27:900-12. [PMID: 33492795 DOI: 10.1002/lt.25996] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 23.0] [Reference Citation Analysis]
Number Citing Articles
1 Hundt MA, Tien C, Kahn JA. Addressing sex-based disparities in liver transplantation. Current Opinion in Organ Transplantation 2022;Publish Ahead of Print. [DOI: 10.1097/mot.0000000000001040] [Reference Citation Analysis]
2 Singh J, Iriana S, Han H, Kahn J. Vaccination for coronavirus disease 2019 in liver transplantation candidates should be recommended but not mandated. Clinical Liver Disease 2022;20:154-156. [DOI: 10.1002/cld.1268] [Reference Citation Analysis]
3 Flemming JA, Muaddi H, Djerboua M, Neves P, Sapisochin G, Selzner N. Association between social determinants of health and rates of liver transplantation in individuals with cirrhosis. Hepatology 2022;76:1079-89. [PMID: 35313040 DOI: 10.1002/hep.32469] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Jones PD, Bailey DD, Damas OM, Ballester V, Vargas E, Mendoza-Ladd A; Inaugural Cohort of AGA FORWARD Program Scholars. Promoting the Pipeline of Diverse Individuals Within Gastroenterology: Reflections From AGA FORWARD Program Scholars. Gastroenterology 2022;163:563-7. [PMID: 35879136 DOI: 10.1053/j.gastro.2022.06.078] [Reference Citation Analysis]
5 Kardashian A, Serper M, Terrault N, Nephew LD. Health disparities in chronic liver disease. Hepatology 2022. [PMID: 35993341 DOI: 10.1002/hep.32743] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Imig JD. Frontiers in metabolic physiology grand challenges. Front Physiol 2022;13:879617. [DOI: 10.3389/fphys.2022.879617] [Reference Citation Analysis]
7 Nephew LD, Aitcheson G, Iyengar M. The Impact of Racial Disparities on Liver Disease Access and Outcomes. Curr Treat Options Gastro 2022;20:279-294. [DOI: 10.1007/s11938-022-00390-1] [Reference Citation Analysis]
8 Gray C, Arney J, Clark JA, Walling AM, Kanwal F, Naik AD. The chosen and the unchosen: How eligibility for liver transplant influences the lived experiences of patients with advanced liver disease. Soc Sci Med 2022;305:115113. [PMID: 35690034 DOI: 10.1016/j.socscimed.2022.115113] [Reference Citation Analysis]
9 Listabarth S, König D, Berlakovich G, Munda P, Ferenci P, Kollmann D, Gyöeri G, Waldhoer T, Groemer M, van Enckevort A, Vyssoki B. Sex Disparities in Outcome of Patients with Alcohol-Related Liver Cirrhosis within the Eurotransplant Network—A Competing Risk Analysis. JCM 2022;11:3646. [DOI: 10.3390/jcm11133646] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Tejedor M, Selzner N, Berenguer M. Are MELD and MELDNa Still Reliable Tools to Predict Mortality on the Liver Transplant Waiting List? Transplantation 2022. [PMID: 35594480 DOI: 10.1097/TP.0000000000004163] [Reference Citation Analysis]
11 Singh ME, James SP, Germino GG, Rodgers GP. Achieving Health Equity Through Digestive Diseases Research and Scientific Workforce Diversity. Gastroenterology 2022;162:1597-1601.e1. [PMID: 35007515 DOI: 10.1053/j.gastro.2022.01.005] [Reference Citation Analysis]
12 Shavelle RM, Saur RC, Kwak JH, Brooks JC, Hameed B. Life Expectancy after Liver Transplantation for NASH. Prog Transpl. [DOI: 10.1177/15269248221087441] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Nash R, Russell MC, Miller-Kleinhenz JM, Collin LJ, Ross-Driscoll K, Switchenko JM, McCullough LE. Understanding gastrointestinal cancer mortality disparities in a racially and geographically diverse population. Cancer Epidemiol 2022;77:102110. [PMID: 35144126 DOI: 10.1016/j.canep.2022.102110] [Reference Citation Analysis]
14 Marinho L, Carneiro FOAA, Costa LJS, Garcia JHP, Nobre-e-souza MÂ, Souza MHLPD. BILIARY FISTULAS ASSOCIATED WITH LIVER TRANSPLANTATION VERSUS OTHER ETIOLOGIES: WHAT IS THE SUCCESS RATE OF THE ENDOSCOPIC TREATMENT? ABCD, arq bras cir dig 2022;35. [DOI: 10.1590/0102-672020220002e1685] [Reference Citation Analysis]
15 Goyes D, Nsubuga JP, Medina-Morales E, Barba R, Patwardhan V, Saberi B, Fricker Z, Bonder A. Race/Ethnicity Is Not Independently Associated with Risk of Adverse Waitlist Removal among Patients with HCC Exception Points. J Clin Med 2021;10:5826. [PMID: 34945122 DOI: 10.3390/jcm10245826] [Reference Citation Analysis]
16 Ge J, Ku E, Roll GR, Lai JC. An Analysis of Free-Text Refusals as an Indicator of Readiness to Accept Organ Offers in Liver Transplantation. Hepatol Commun 2021. [PMID: 34783178 DOI: 10.1002/hep4.1865] [Reference Citation Analysis]